EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

Additional Metadata
Keywords	Biological antirheumatic drugs, Disease-modifying antirheumatic drugs, EULAR recommendations, Managements of rheumatoid arthritis, Synthetic antirheumatic drugs
Persistent URL	doi.org/10.1136/annrheumdis-2013-204573, hdl.handle.net/1765/68716
Journal	Annals of the Rheumatic Diseases: an international peer-reviewed journal for health professionals and researchers in the rheumatic diseases
Organisation	Rheumatology
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Smolen, J., Landewé, R., Breedveld, F., Buch, T., Burmester, G., Dougados, M., Emery, P., Gaujoux-Viala, C., Gossec, L., van Nam, N., Ramiro, S., Winthrop, K., M. de Wit (Maarten), Aletaha, D., Betteridge, N., Bijlsma, H., Boers, M., Buttgereit, F., Combe, B., … van der Heijde, D. (2014). EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Annals of the Rheumatic Diseases: An International Peer-reviewed Journal for Health Professionals and Researchers in the Rheumatic Diseases, 73(3), 492–509.https://doi.org/10.1136/annrheumdis-2013-204573

Publication